Halozyme Therapeutics Shares Down 34.0% Since SmarTrend's Sell Call (HALO)
October 08, 2015 at 10:21 AM EDT
SmarTrend identified a Downtrend for Halozyme Therapeutics (NASDAQ:HALO) on August 7th, 2015 at $21.25. In approximately 2 months, Halozyme Therapeutics has returned 34.01% as of today's recent price of...